ERYTECH PHARMA - SPON ADR (ERYP)
US29604W1080 - ADR
ChartMill assigns a Buy % Consensus number of 42% to ERYP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.94. This target is 405.11% above the current price.
ERYP was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about ERYP.
In the previous month the buy percentage consensus was at a similar level.
ERYP was analyzed by 9 analysts. More opinions would make the average more meaningful.